2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate

C140H272N24O16 — CID 158320408

IUPAC2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate
SMILESCC(C)C(=O)NC1CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CC(C)N1CCC(C)(NC(=O)OC2CCOC2)CC1.CC(C)N1CCC(C)(NC(=O)OCC2CC2)CC1.CC(C)N1CCC(CN(C)C)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC2CC2)CC1.CCN1CCN(CC2(NC(=O)OCC(C)C)CCN(C(C)C)CC2)CC1.CCOC(=O)NC1(C)CCN(C(C)C)CC1
InChIInChI=1S/C20H40N4O2.C18H33N3O2.C18H35N3O2.C16H31N3O.C16H33N3O.C14H26N2O3.C14H26N2O2.C12H24N2O2.C12H24N2O/c1-6-22-11-13-23(14-12-22)16-20(21-19(25)26-15-17(2)3)7-9-24(10-8-20)18(4)5;1-15(2)21-7-5-18(6-8-21,14-20-9-11-23-12-10-20)19-17(22)13-16-3-4-16;1-15(2)13-17(22)19-18(14-20-9-11-23-12-10-20)5-7-21(8-6-18)16(3)4;1-13(2)19-9-7-16(8-10-19,12-18(3)4)17-15(20)11-14-5-6-14;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-11(2)16-7-5-14(3,6-8-16)15-13(17)19-12-4-9-18-10-12;1-11(2)16-8-6-14(3,7-9-16)15-13(17)18-10-12-4-5-12;1-5-16-11(15)13-12(4)6-8-14(9-7-12)10(2)3;1-9(2)12(15)13-11-5-7-14(8-6-11)10(3)4/h17-18H,6-16H2,1-5H3,(H,21,25);15-16H,3-14H2,1-2H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);13-14H,5-12H2,1-4H3,(H,17,20);13-14H,7-12H2,1-6H3,(H,17,20);11-12H,4-10H2,1-3H3,(H,15,17);11-12H,4-10H2,1-3H3,(H,15,17);10H,5-9H2,1-4H3,(H,13,15);9-11H,5-8H2,1-4H3,(H,13,15)
InChIKeyGOTVUZIWBPKKCD-UHFFFAOYSA-N
MW2547.87 g/mol
LogP16.89
Rot. Bonds44

About 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate

2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate (PubChem CID 158320408) has the molecular formula C140H272N24O16 and a molecular weight of 2547.87 g/mol. Its IUPAC name is 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate.

Molecular Properties

Compound Name2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate
PubChem CID158320408
Molecular FormulaC140H272N24O16
Molecular Weight2547.87 g/mol
Exact Mass2546.12
IUPAC Name2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate
SMILESCC(C)C(=O)NC1CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CC(C)N1CCC(C)(NC(=O)OC2CCOC2)CC1.CC(C)N1CCC(C)(NC(=O)OCC2CC2)CC1.CC(C)N1CCC(CN(C)C)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC2CC2)CC1.CCN1CCN(CC2(NC(=O)OCC(C)C)CCN(C(C)C)CC2)CC1.CCOC(=O)NC1(C)CCN(C(C)C)CC1
InChIInChI=1S/C20H40N4O2.C18H33N3O2.C18H35N3O2.C16H31N3O.C16H33N3O.C14H26N2O3.C14H26N2O2.C12H24N2O2.C12H24N2O/c1-6-22-11-13-23(14-12-22)16-20(21-19(25)26-15-17(2)3)7-9-24(10-8-20)18(4)5;1-15(2)21-7-5-18(6-8-21,14-20-9-11-23-12-10-20)19-17(22)13-16-3-4-16;1-15(2)13-17(22)19-18(14-20-9-11-23-12-10-20)5-7-21(8-6-18)16(3)4;1-13(2)19-9-7-16(8-10-19,12-18(3)4)17-15(20)11-14-5-6-14;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-11(2)16-7-5-14(3,6-8-16)15-13(17)19-12-4-9-18-10-12;1-11(2)16-8-6-14(3,7-9-16)15-13(17)18-10-12-4-5-12;1-5-16-11(15)13-12(4)6-8-14(9-7-12)10(2)3;1-9(2)12(15)13-11-5-7-14(8-6-11)10(3)4/h17-18H,6-16H2,1-5H3,(H,21,25);15-16H,3-14H2,1-2H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);13-14H,5-12H2,1-4H3,(H,17,20);13-14H,7-12H2,1-6H3,(H,17,20);11-12H,4-10H2,1-3H3,(H,15,17);11-12H,4-10H2,1-3H3,(H,15,17);10H,5-9H2,1-4H3,(H,13,15);9-11H,5-8H2,1-4H3,(H,13,15)
InChIKeyGOTVUZIWBPKKCD-UHFFFAOYSA-N
XLogP16.89
TPSA375.11 Ų
H-Bond Donors9
H-Bond Acceptors31
Rotatable Bonds44
Heavy Atoms180
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002547.87
LogP ≤ 516.89
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
The IUPAC name of 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate (CID 158320408) is 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate.
What is the SMILES notation for 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
The canonical SMILES for 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate is CC(C)C(=O)NC1CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CC(C)N1CCC(C)(NC(=O)OC2CCOC2)CC1.CC(C)N1CCC(C)(NC(=O)OCC2CC2)CC1.CC(C)N1CCC(CN(C)C)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC2CC2)CC1.CCN1CCN(CC2(NC(=O)OCC(C)C)CCN(C(C)C)CC2)CC1.CCOC(=O)NC1(C)CCN(C(C)C)CC1.
What is the InChIKey of 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
The InChIKey is GOTVUZIWBPKKCD-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H40N4O2.C18H33N3O2.C18H35N3O2.C16H31N3O.C16H33N3O.C14H26N2O3.C14H26N2O2.C12H24N2O2.C12H24N2O/c1-6-22-11-13-23(14-12-22)16-20(21-19(25)26-15-17(2)3)7-9-24(10-8-20)18(4)5;1-15(2)21-7-5-18(6-8-21,14-20-9-11-23-12-10-20)19-17(22)13-16-3-4-16;1-15(2)13-17(22)19-18(14-20-9-11-23-12-10-20)5-7-21(8-6-18)16(3)4;1-13(2)19-9-7-16(8-10-19,12-18(3)4)17-15(20)11-14-5-6-14;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-11(2)16-7-5-14(3,6-8-16)15-13(17)19-12-4-9-18-10-12;1-11(2)16-8-6-14(3,7-9-16)15-13(17)18-10-12-4-5-12;1-5-16-11(15)13-12(4)6-8-14(9-7-12)10(2)3;1-9(2)12(15)13-11-5-7-14(8-6-11)10(3)4/h17-18H,6-16H2,1-5H3,(H,21,25);15-16H,3-14H2,1-2H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);13-14H,5-12H2,1-4H3,(H,17,20);13-14H,7-12H2,1-6H3,(H,17,20);11-12H,4-10H2,1-3H3,(H,15,17);11-12H,4-10H2,1-3H3,(H,15,17);10H,5-9H2,1-4H3,(H,13,15);9-11H,5-8H2,1-4H3,(H,13,15).
What are the key properties of 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate has a molecular weight of 2547.87 g/mol, XLogP of 16.89, 44 rotatable bonds, 9 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;2-methylpropyl N-[4-[(4-ethylpiperazin-1-yl)methyl]-1-propan-2-ylpiperidin-4-yl]carbamate;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate is sourced from PubChem (CID 158320408), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).